Use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction and pharmaceutical or dietetic compositions containing such bacteria
AssigneeMendes Inc.
InventorClaudio De Simone
Life of this patent
Estimating the term…
Abstract
Disclosed is the use of bacteria endowed with arginine deiminase to induce apoptosis and/or reduce an inflammatory reaction, and pharmaceutical or dietetic compositions containing such bacteria. Also included is a strain of Lactobacillus brevis highly endowed with arginine deiminase.
Claims7
A biologically pure strain of Lactobacillus brevis CD2 deposited with the DSM-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Brunswick, Germany, under the access number DSM 11988, having an activity of arginine deiminase expressed as picomols citrulline/mg bacterial proteins/min of not less than 0.1 and their descendants, mutants and derivatives which possess said activity.
Dependencies are inferred from the claim text.